NF-κB: A novel therapeutic pathway for gastroesophageal reflux disease?

doi:10.12998/wjcc.v10.i24.8436

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 10, Issue 24

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2450)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series.

Item

Count

PDF

156

WORD

HTML

1297

Figures (1-1)

358

Sum=1859

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

226

Download

365

Sum=591

Aug 26, 2022 (publication date) through May 7, 2024

Times Cited of This Article

Times Cited (2)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Opinion Review

World J Clin Cases. Aug 26, 2022; 10(24): 8436-8442
Published online Aug 26, 2022. doi: 10.12998/wjcc.v10.i24.8436

Open in New Tab Full Size Figure Download Figure

Figure 1 Mechanisms of gastroesophageal reflux.

Citation: Zhang ML, Ran LQ, Wu MJ, Jia QC, Qin ZM, Peng YG. NF-κB: A novel therapeutic pathway for gastroesophageal reflux disease? World J Clin Cases 2022; 10(24): 8436-8442
URL: https://www.wjgnet.com/2307-8960/full/v10/i24/8436.htm
DOI: https://dx.doi.org/10.12998/wjcc.v10.i24.8436